News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX health stocks: Proteomics tumbles 22pc on delayed product launch, Race hits 10mth highs
News
Top 10 at 10: AI, big gold hits, and a $65m cash windfall
News
Hot Money Monday: ‘Cut losses and let winners run’ – advice from legendary momentum trader Paul Tudor Jones
Health & Biotech
ASX Health Stocks: Neuren’s sales come in at top of guidance range, crushing short seller’s claims
News
Market Highlights: Bitcoin up again, Microsoft makes another huge AI bet, and 5 ASX small caps to watch
Health & Biotech
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
ScoPo’s Powerplays: Nanosonics ‘in the doghouse’, but ASX health stocks are largely being good boys
Health & Biotech
ScoPo’s Powerplays: ASX healthcare rises in Christmas rally as EBOS ups stake in Transmedic
Health & Biotech
ScoPo gives his NINE picks to fill the Christmas stocking with some ASX health stocks
Health & Biotech
ASX Health Stocks: Neuren to start Phase 2 trial soon; Proteomics expands footprint in South America
Health & Biotech
ASX Health Stocks: Mesoblast partners up for pivotal trial, Alterity in $4.8 million cap raise
Health & Biotech
ASX Biotech September Winners: Healthcare down 5pc, but experts say it’s still best sector in a recession
News
In Case You Missed It: Medicare milestone and provisional ports approval
News
ASX Health Stocks: Proteomics soars 13pc after US sets reimbursement price for PromarkerD
News
Top 10 at 11: It’s a mixed up kinda morning, but we’re moving in the right direction… for now
Health & Biotech